We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




X chromosome Genes Linked to Male Infertility

By LabMedica International staff writers
Posted on 12 Jul 2022

Male infertility can be caused by low sperm production, abnormal sperm function or blockages that prevent the delivery of sperm. More...

Illnesses, injuries, chronic health problems, lifestyle choices and other factors may contribute to male infertility.

Although the evolutionary history of the X chromosome indicates its specialization in male fitness, its role in spermatogenesis has largely been unexplored. Currently only three X chromosome genes are considered of moderate-definitive diagnostic value.

A large international team of medical scientists led by the University of Florence (Florence, Italy) used targeted X chromosome sequencing or exome sequencing to search for genetic contributors to infertility in more than 2,350 men with idiopathic forms of non-obstructive azoospermia or cryptozoospermia that could not be explained using conventional diagnostic methods. Genomic data were analyzed and compared with data in normozoospermic control individuals and Genome Aggregation Database (gnomAD) database (Broad Institute, Cambridge, MA, USA).

The team flagged hundreds of X chromosome genes that were recurrently mutated in men with infertility. When they whittled that set down by considering associations within and across cohorts, they identified 21 genes with the strongest spermatogenic ties and another 34 genes with more modest associations. When the team took the most pronounced infertility associations forward for targeted sequence analyses in another 265 men with non-obstructive azoospermia/cryptozoospermia and 54 non-obstructive azoospermia patients, it identified nine infertile men carrying variants in half a dozen of the genes. Still other genes in the candidate set had weaker links to infertility across the replication cohort.

The investigators validated suspected associations, explored protein interaction profiles for candidate infertility contributors, and searched for other genes that had higher-than-usual mutation burdens in infertile men compared with their fertile counterparts. The most frequently affected prioritized gene, RBBP7, was found mutated in ten men across all cohorts.

Csilla Krausz, MD, PhD, an Endocrinologist and a senior author of the study, said, “Our analysis represents a substantial step toward reducing the gap in our understanding of X-linked genetic causes of spermatogenic failure.”

The authors concluded that collectively, their study represents a significant step towards the definition of the missing genetic etiology in idiopathic severe spermatogenic failure and significantly reduces the knowledge gap of X-linked genetic causes of azoospermia contributing to the development of future diagnostic gene panels. The study was published on July 8, 2022 in the American Journal of Human Genetics.

Related Links:
University of Florence 
Genome Aggregation Database


New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.